In the realm of laboratory equipment, precision and safety are paramount, and Zhongke Meiling has once again raised the bar with its latest centrifuge release. Combining cutting-edge technology and user-friendly features, this new models has quickly garnered accolades from a diverse range of users, solidifying its reputation as a leading choice.
Serving as an indispensable laboratory apparatus, centrifuges cater to varied user requirements across blood stations, pharmaceuticals, university research facilities, and healthcare institutions. Centrifuge uses an efficient separation technology, widely used in pharmaceutical, chemical, food and other fields. The centrifuge separates the mixture by utilizing the different sedimentation coefficients of materials under different centrifugal forces to obtain the target product. It has important applications in the preparation of biological products, separation of suspensions and other processes.
Introducing New Arrival Centrifuges
Centrifugation is a crucial technique in many laboratory procedures, and the accuracy of this process can significantly impact experimental outcomes. From clinical diagnostics to biochemical research, achieving precise separation of components is essential.CT-G185R is designed to meet these high standards, ensuring that researchers can trust the results of their experiments. One of the most impressive attributes of the new centrifuge is its remarkable maximum centrifugal force of 32,531 xg, enabling rapid cooling in just 4 minutes. This unparalleled speed is a game changer for laboratories that demand both efficiency and precision. And the centrifuge maintains a rotational speed precision of ±10 rpm, temperature accuracy of ±1℃, crucial for experiments that require strict temperature and speed controls.
Furthermore, Safety in laboratory environments is paramount, which is why this new model features an automatic shutdown protection alarm due to rotor imbalance, significantly enhancing experimental safety and reducing the risk of equipment damage. Also equipped with multi-stage damping design, the amplitude of the whole machine reaching as low as to 0.003mm, further ensuring precision in sensitive experiments.
Compatible with the requirements of different centrifugal high and low speed, it ensures that the temperature can be reduced from normal temperature to 4°C in the fastest 4 minutes under cooling state, and the temperature control accuracy is maintained at ±1°C, with precise temperature and speed control, truly achieving multiple uses of one machine. It has the functions of instantaneous centrifugation, step centrifugation and one-button precooling to meet the needs of different centrifugal experiments. Quiet yet powerful, the CT-Q175R redefines operational convenience, setting a new standard in the industry. Achieve peak performance with speeds soaring up to 17,500 rpm and forces reaching 29102 x g, propelling your research to new heights with unmatched precision and reliable. Elevate your laboratory's capabilities with the its extensive rotor options, its formidable motor, and user-friendly control panel, all complemented by a robust refrigeration system and an array of versatile accessories.
User Praise and Feedback
The initial feedback from users regarding Zhongke Meiling's latest centrifuge models has been overwhelmingly positive. Users have remarked, "The automatic rotor recognition and locked speed range significantly enhance centrifugal safety," as well as praising the "stylish ergonomic design and intuitive touch screen interface." Additionally, they noted, "The professionally managed operations ensure enhanced safety during centrifugation." Our array of innovative product features has garnered unanimous acclaim on a global scale.
To further elevate user satisfaction, Zhongke Meiling is focused on fostering innovation within the life sciences and healthcare sectors by accelerating technological advancement and broadening our digital solutions. We remain committed to delivering precision centrifugal solutions tailored to diverse applications, while significantly augmenting the technological capabilities of global health infrastructure.
